Low Level Light Therapy (LLLT) for Age-related Macular Degeneration

Dry Age-related Macular Degeneration (AMD) is a progressive retinal disease due to aging. It involves the accumulation of Drusen that eventually leads to degeneration of the Photoreceptors and Retinal Pigment Epithelium (RPE), resulting in irreversible loss of central vision. It is the leading cause of blindness in the developed world.

The main risk factor for Dry AMD is age. There is limited therapeutic options in Dry AMD, beyond dietary advice (Diets rich in antioxidants and AREDS supplements in suitable cases) and smoking cessation.

Photobiomodulation with Low Level Light Therapy (LLLT) is a pioneering treatment for Dry AMD. The technology uses LED light that acts on retina to boost cells energy and reducing oxidative stress, thus slowing down the progression of AMD.

The LightWave I Study, a multicentre, randomised double-masked controlled trial, has shown that PBM with LLLT significantly reduceddrusen volume and significantly improved visual acuity, proving its potential to slowing the progression of the disease and preventing its advanced stages.

> Safe
> Non-invasive
> Painless
> Fast (12′ Both Eyes)

The Medical Eye Clinic is the first centre in the Southwest to introduce LLLT for AMD. Our team of experienced and friendly staffs are trained to deliver the treatment in a safe and comfortable environment.

To find out if you are eligible for this treatment, please contact us directly to arrange a comprehensive macular assessment by our expert retinal specialists.